Akeso shares hit a record high after the company said its closely watched lung cancer drug definitively demonstrated that it could help some patients live longer for the first time, potentially boosting its prospects for approval in the U.S.
The
Akeso shares surge as cancer drug achieves key milestone in China trial
2 hours ago
1
Related
EU’s 2035 zero-emissions car target ‘no longer feasible,’ au...
17 minutes ago
0
‘Tariffs so high, your head’s going to spin’: Trump explains...
19 minutes ago
0
ganesh chaturthi wishes to share with friends family message...
35 minutes ago
0
Trump admin outlines rare earth plan to break China's domina...
43 minutes ago
0
Hafnia GAAP EPS of $0.15, revenue of $346.6M
1 hour ago
0
Nerdy gets new operations chief
1 hour ago
0
Champion Iron CFO steps down
1 hour ago
0
XCF Global receives Nasdaq compliance notice
2 hours ago
0
Popular
Blue Moon Metals gets $400M project finance
6 days ago
4
English (US) · © FBT Company 2025. All rights are reserved